Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed) | PA 18 531

Opportunity Information: Apply for PA 18 531

The National Institutes of Health (NIH) funding opportunity titled "Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed)" is a small research grant program designed to encourage focused, early-stage studies that examine how experiences and exposures earlier in life can shape cancer risk much later. The central idea behind the announcement is that cancer prevention may be improved if researchers can identify how factors occurring before birth and through early adulthood influence biological pathways involved in carcinogenesis, and if they can develop measurable indicators that signal elevated risk long before a cancer diagnosis would normally occur.

This FOA is specifically interested in research spanning a wide window of early development, including maternal and paternal influences, in utero conditions, birth outcomes, infancy, puberty, adolescence, and young adulthood. NIH is seeking projects that clarify which early-life factors are associated with later cancer development, how those factors may alter biological processes relevant to cancer initiation and progression, and whether early biological changes can be captured through predictive markers that could eventually be used in cancer prevention strategies. A key motivation is practical: if researchers can validate markers of malignancy risk or pre-malignant changes that reflect early-life exposures, the field would not have to wait decades for cancer outcomes to appear in order to evaluate the long-term impact of those exposures.

The opportunity places strong emphasis on mechanism and measurement. In addition to identifying associations between early exposures and later cancer, applicants are encouraged to investigate how early-life events may mediate or program biological systems in ways that influence carcinogenesis. This can include exploring how developmental timing affects susceptibility, how physiological changes during critical growth periods might alter later cancer risk, and what intermediate endpoints (biomarkers or other measurable traits) could serve as earlier readouts of risk. The long-term goal is to build a mechanistic foundation that could support targeted interventions during pregnancy or early life, when preventive actions might have an especially large effect on lifetime cancer risk.

Administratively, this is an R03 mechanism, which is commonly used by NIH for short, discrete projects such as pilot studies, feasibility work, secondary data analyses, method development, or early hypothesis-testing efforts that can generate preliminary evidence for larger future grants. The FOA explicitly states "Clinical Trial Not Allowed," meaning the proposed research should not include prospective assignment of human participants to interventions to evaluate health-related outcomes. Applicants can still generally propose human subjects research that is observational in nature, uses existing cohorts or biospecimens, analyzes registries or biobanks, or develops and validates predictive markers without running an interventional clinical trial.

The program is listed as a discretionary grant under the NIH, with the activity category noted as education and health and a CFDA number of 93.393. The source information lists an award ceiling of $50,000. The original closing date shown is January 7, 2021, and the FOA was created on December 20, 2017, which is helpful for understanding the historical context of the announcement and its timeline.

Eligibility is broad and includes many types of U.S. organizations and governments, such as state, county, city or township governments, special district governments, independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (both 501(c)(3) and non-501(c)(3)), for-profit organizations (other than small businesses), and small businesses. It also includes Native American tribal governments that are federally recognized, as well as tribal organizations that are not federally recognized tribal governments, plus public housing authorities and Indian housing authorities. The FOA also highlights additional eligible applicant categories, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based and community-based organizations, regional organizations, U.S. territories or possessions, and non-U.S. entities (foreign organizations).

Overall, the opportunity is aimed at accelerating research that connects early developmental environments and exposures to cancer risk later in life, with a particular push toward uncovering mechanisms and identifying measurable early indicators of risk. The practical payoff NIH is signaling is a future where prevention is informed by early-life biology and risk markers, enabling earlier assessment and potentially earlier intervention, rather than relying solely on cancer outcomes that may not appear until many years after the relevant exposures occurred.

• The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393.
• This funding opportunity was created on 2017-12-20.
• Applicants must submit their applications by 2021-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $50,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PA 18 531

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: